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Abstract: Type 1 diabetes is clinically characterized as the loss of control of glucose homeostasis due to the reduced number of insulinproducing cells. Long-term glycemic control after implantation could be maintained by preserving the cell viability and tissue-specific
functions during the process of microencapsulation. In this study, alginate solution was supplemented with platelet-rich plasma (PRP)
to improve the viability and preserve the cell functions during the encapsulation of a beta cell line (BRIN-BD11). Cell viability was
assessed and insulin secretion and insulin stimulation index were evaluated. The polymerization of alginate with PRP enhanced the
viability up to 61% in the alginate microbeads. PRP supplementation to the alginate composition not only increased the number of
viable cells by 1.95-fold, but the insulin secretion also improved by about 66%. The stimulation index, however, was not affected by the
PRP supplementation.
Key words: Calcium alginate microbeads, diabetes, droplet method, pancreatic beta cells, insulin

1. Introduction
The transplantation of insulin-producing beta cells or
pancreatic islets promises a cure for insulin-dependent
(type 1) diabetes. Due to the constant attacks of the
immune system, the protection of these cells is essential.
Microencapsulation in alginate is the longest and most
commonly applied technology for immunoisolation of
pancreatic islets/beta cells (Zimmermann et al., 2001;
Bhujbal et al., 2014). So far, various encapsulation
techniques have been developed, but biocompatibility,
stability, and permeability of the polymers are the main
factors for a successful clinical application (Prüsse et
al., 2008; de Vos et al., 2009). The initially insufficient
beta cell mass or the compromised survival of implants
is considered to play a critical role in the low efficiency
of treatment (Jacobs-Tulleneers-Thevissen et al., 2013).
Due to the processing method of alginate microcapsules,
viability could be significantly decreased and even become
unsuitable for transplantation.
The materials supplemented into microbeads during
their generation might change the stability, permeability,
and cellular events. The type of cationic agents in the
polymerization of alginate, for example, determines the
physiological properties of the polymer, like rigidity and

stability. Poly-L-histidine (PLH) is a homo-amine cationic
polymer that shows pH-dependent amphoteric properties.
The ionization of PLH below a specific pH level was
reported to change its characteristics from hydrophobic to
hydrophilic (Lee et al., 2003a, 2003b). This polymer has
been known as the pH-sensitive part of pH-responsive
nanoparticles. At physiological pH, this polymer is in
its hydrophobic state, but its physiochemical properties
change below this pH level (Wu et al., 2013; Coue and
Engbersen et al., 2015; Bilalis et al., 2016).
The physiochemical properties of the microcapsules
might be improved, but it is not always sufficient for the
survival of cells. Platelet-rich plasma (PRP) is a blood
product that contains high concentrations of diverse
growth factors, such as TGF-β1, VEGF, and PDGF, which
can stimulate cell proliferation, migration, differentiation,
and angiogenesis so that tissue regeneration could be
improved (Kakudo et al., 2014; Kushida et al., 2014).
Applications with PRP have become popular in recent
years in the fields of neurosurgery and general surgery
(Dohan Ehrenfest et al., 2014).
In the present study, we compared the effect of PRP
supplementation to alginate-encapsulated pancreatic beta
cell (BRIN-BD11) preparations on the viability and the
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glucose-responsive character of the cells. Three different
commercially available alginate powders were tested for
stable structure, and PLH was used as a cationic agent
in the encapsulation during the process. The aim was to
improve the microbeads for functional implants to be used
in the treatment of diabetes by utilizing the supportive
effect of PRP. The released insulin level to the medium was
analyzed for different glucose concentrations to determine
the beta cell function.
2. Materials and methods
2.1. Cell culture
A glucose-responsive rat cell line, BRIN-BD11, a hybrid
cell line of a primary culture of NEDH rat pancreatic islets
and RINm5F, was used in the encapsulation. The cells were
cultured in RPMI 1640 culture medium (GIBCO, Paisley,
UK) supplemented with 10% fetal bovine serum (FBS;
GIBCO) and 1% Pen-Strep (GIBCO). For the passage,
cells were washed with phosphate-buffered saline (PBS;
GIBCO) prior to detachment from tissue culture flasks
with 0.25% (w/v) trypsin-EDTA (GIBCO) and seeded at
2.0 × 105 cells per T75 culture flask.
2.2. PRP preparation
PRP was obtained from blood of Fischer 344 (F344) inbred
rats (n = 9) by the 2-step centrifugation method (Nagata,
2010). The blood samples were collected in a vacuum
tube (BD Vacutainer; BD, Plymouth, UK) containing
sodium citrate buffer (0.1 M). The blood cell component
was removed from the medium by centrifugation at 160
× g for 20 min at room temperature. The upper fraction
was transferred into a new tube, where it was centrifuged
at 400 × g for 15 min at 4 °C to separate PRP from the
serum component. The final fraction contained 6.2 × 106
platelets/mL.
2.3. Production of microcapsules
Three different alginate powders were used for the alginate
formulation: alginate of low viscosity (4–12 cP, 1% in H2O;
Sigma-Aldrich, St. Louis, MO, USA; C.N.: A1112), alginate
of high viscosity (≥2000 cP, 2% in H2O; Sigma-Aldrich;
C.N.: A2033), and alginate of medium viscosity (SigmaAldrich, C.N.: 71238). Alginate solution (1.5%) was
prepared in low-glucose basal medium (DMEM with 5.5
mM glucose) supplied with 1% Pen-Strep. PRP was mixed
with alginate solution (1:20, v/v) prior to the addition of
cells (2.0 × 106 cells /mL). The mixed solution was drawn
using a syringe with a 30-G needle (BD, Franklin Lakes,
NJ, USA) and gradually dropped into a cross-linking bath
containing 100 mM CaCl2 at the rate of 1 mL/min. After
5 min of reaction, the microbeads were collected in a cell
strainer (100 µm; BD) and then washed with PBS.
The microbeads were incubated in PLH solution (100
mM; Santa Cruz Biotechnology, Heidelberg, Germany)
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for 10 min at room temperature. PLH-coated spheres were
then washed with PBS before an outer alginate layer was
coated [0.4% (w/v) in DMEM] for 10 min. The microbeads
with cells were maintained in low-glucose (5.5 mM)
DMEM supplemented with 10% FBS and 1% Pen-Strep.
2.4. Swelling ratio of microcapsules
After the microbeads were generated, they were air-dried
and the weight was recorded. Then the beads were soaked
in PBS buffer (pH 7.4; Thermo, GIBCO) at 37 °C. At
different time points, the wet weight of microcapsules was
measured after removing the excess fluid and the swelling
ratio was calculated according to the formulation given by
Sarker et al. (2014).
2.5. pH response of poly-L-histidine coated microcapsules
The effect of pH on protein release from the microcapsules
was analyzed by mixing bovine serum albumin (BSA;
Sigma) at a final concentration of 1 mg/mL into the
alginate composition. After coating the microcapsules
with poly-L-histidine, the microcapsules were soaked in
0.1 M phosphate buffer with different pH values varying
from 5.0 to 8.0. The released protein level was measured
by bicinchoninic acid (BCA) assay (Duruksu et al. 2018).
2.6. Assessment of cell viability
The cell viability was assessed by WST1 assay and Calcein
AM staining. Following the culture, the culture medium
was replaced with basal medium (DMEM with 5.5 mM
glucose) including 10% WST1 reagent (Roche, Mannheim,
Germany). After incubation for 1 h, the absorbance was
measured at 450 nm.
The cell viability in microbeads was determined
by staining with Calcein AM (4 mM) and ethidium
homodimer-1 (2 mM), according to the instructions for
the live-dead staining kit (Invitrogen, Eugene, OR, USA).
Cells containing microbeads were incubated for 30 minutes
in 2 mL of serum-free medium containing 1 mL of Calcein
AM and 2 mL of ethidium homodimer-1. Subsequently,
capsules were washed and visualized under a fluorescence
microscope (Leica DMI 4000B, Wetzlar, Germany). Dead
cells exhibited red fluorescence and viable cells green.
2.7. Insulin assay and response to glucose
Insulin level in the medium was estimated by rat insulin
ELISA kit (Millipore, Billerica, MA, USA) according to
the manufacturer’s instructions. The minimum detectable
dose of the ELISA kit was reported as 0.2 ng/mL. All
experiments were repeated at least three times. Total
protein in the medium was measured by the BCA assay
using fresh culture medium as a blank.
To determine the cell response to varying glucose
concentrations, the insulin levels were determined
in the same basal medium with two different glucose
concentrations. The microbeads were incubated for 24 h
either in low-glucose DMEM (5.5 mM) or in high-glucose
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DMEM (25 mM). The sample from each medium was
collected to estimate the insulin levels by ELISA.
2.8. Statistical analysis
Statistical differences in the groups were analyzed with
two-tailed, nonpaired Student t-tests assuming unequal
variance. Results are expressed as mean ± standard
deviation (SD). The validity of the data was evaluated by
the Fisher exact test. All statistical analyses were performed
using SPSS 10.0 (SPSS Inc., Chicago, IL, USA). The results
were considered statistically significant when P < 0.05 and
highly significant when P < 0.01.
3. Results
Three different alginate powders with different viscosity
degrees were used for the preparation of the encapsulation,
which provides diverse properties to the spheres after
their polymerization. The cell-free polymerization
studies showed that the formulation with low viscosity
was not suitable for encapsulation: the structures were
neither uniform nor spherical in shape (Figure 1a). The
medium and highly viscous alginate formulations gave
solid, uniform, and spherical structures, and the addition
of PRP did not change their morphology significantly
(Figures 1b and 1c). The coating of spheres with PLH was
successfully employed and the thickness of the coating
could be regulated by increasing the incubation time
(Figures 2a–2d). Both types of the alginate microbeads
kept their physical structure intact during the study. PRP
addition or coating with PLH was not observed to change
the spheres. During the studies with the encapsulated cells,
the structure of microbeads produced from medium and
highly viscous alginates was not disrupted (Figures 2c and
2d). The sizes of the spheres were measured and the size
frequency was evaluated (Figure 3). The size of the alginate
spheres fabricated from the medium viscous alginate
(Med Alg) preparation presented a peak of 23.44% at
approximately 1600 µm (Figure 3a). The spheres made of
highly viscous alginate (High Alg) gave a peak of 24.05%
at approximately 1400 µm (Figure 3b).
The effect of PLH coating and the PRP on the cell
viability and beta cell function were evaluated separately.
The soaking rates of spheres were evaluated to reveal the
microcapsules’ ability to keep and release the buffer at
physiological conditions (pH 7.4, 37 °C), which is related
to the transfer of cell nutrients and metabolites in and out
of the alginate spheres. Overall, the Med Alg group had a
higher soaking rate than the High Alg group (Figure 4).
The rate in the initial period was slow, but it accelerated
with time. The effect of PLH on swelling characteristics
was limited. Although a decrease in swelling rate could
be observed in both alginate preparations, statistically the
effect was insignificant. On the other hand, the addition of
PRP to the formulations considerably affected the swelling.

Figure 1. The cell-free polymerization of alginate solutions with
different viscosity values. Three different alginate products were
used to prepare the microcapsules: a) low viscosity alginate (4–12
cP); b) medium viscosity alginate; and c) high viscosity alginate
(≥2000 cP). Alginate solutions (1.5%) were prepared in lowglucose (5.5 mM) DMEM. The microcapsules were stained with
Congo Red (0.15%; Sigma-Aldrich). Scale bars: 200 µm.
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Figure 2. Encapsulated rat pancreatic beta cells (BRIN-BD11) in alginate hydrogels. The cells were encapsulated in medium viscosity (a)
and high viscosity (b) alginate solutions and coated with PLH (c, d), respectively. Scale bars: 500 µm (a, b), 100 µm (c), and 200 µm (d).

Figure 3. Histograms of particle size distribution frequency of medium and highly viscous alginate formulations. The size distribution
frequency (%) is presented in bars and the size cumulative distribution (%) in continuous line diagram for Med Alg (a) and High Alg (b).
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Figure 4. Swelling ratio in PBS at pH 7.4 as a function of time of the microbeads fabricated from medium (a) and highly (b) viscous
alginate.

The PLH coating of PRP-added microcapsules further
decreased the swelling ratio, which could be related to the
diffusion rate of metabolites. In High Alg microspheres,
the plateau was reached more rapidly than in Med Alg
(Figures 4a and 4b).
As beta cells under normal physiological conditions do
not proliferate substantially in humans, the liquefaction
step in the alginate-polymer-alginate (APA) encapsulation
procedure was not applied to keep the cells in their
nonproliferative state. After the encapsulation process of
beta cells, the viable cell number was determined after
48 h of incubation in the low-glucose DMEM culture
medium. Staining with Calcein AM, which demonstrated
the live/dead cell distribution in the microbeads, showed
a significant number of dead cells (stained in red) after
48 h of incubation in medium alginate formulation with
PLH + PRP compared to the alginate microbeads with
PRP supplementation without the PLH coating (Figures
5a and 5b). The highly viscous alginate microbeads
contained fewer dead cells compared to the medium
alginate groups (Figures 5c and 5d). The metabolically
active cells were quantified by WST1 assay (Figures 5e
and 5f). Statistically significant differences between the
microbeads prepared by medium and highly viscous
alginate formulations (without PRP or PLH) were not
observed. Compared to the alginate-only microcapsules,
the application of PLH improved viability by 27% and 61%
in the medium and highly viscous alginate microbeads.
The effect of PLH coating addition substantially improved
the viable cell numbers in the microbeads, but the

supplementation of alginate mixture with PRP showed
the highest supportive effect in the groups. In the highly
viscous alginate microbeads with PRP, the number of
viable cells was increased almost 2-fold compared to the
control microbeads without PRP (Figure 5f). Surprising
results were obtained from the microbeads when both
PLH coating and PRP addition were performed together.
In the highly viscous alginate microbeads, the number of
metabolically active cells decreased to the level observed
in the single alginate formulation, and the decrease was
even lower in the medium viscous alginate microbeads
with PLH + PRP.
The insulin secretion from the microbeads was
estimated by ELISA after 24 h of incubation of the
microbeads in the low-glucose fresh basal medium (no
serum) following 48 h of incubation under the same
conditions. The level of insulin was normalized by the
total protein in the medium (Figures 6a and 6b). In the
culture with low-glucose medium, an increase in secreted
insulin level was observed in the medium viscous agar
microbeads with PRP and PRP + PLH, at 19.19 ± 1.51 ng/
mg protein and 17.06 ± 1.07 ng/mg protein, respectively.
The insulin secretion level of PLH (14.36 ± 1.48 ng/mg
protein) was not significantly different from the alginateonly microbeads (Med Alg) at 12.27 ± 1.05 ng/mg protein
(Figure 6a). The insulin secretion from the highly viscous
alginate group (no PRP or PLH) was higher than that of
the medium viscous alginate microbeads (Figure 6b). The
insulin secretion levels between the groups of the highly
viscous alginate preparations were almost the same,
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Figure 5. Cell viability in the microcapsules. The medium viscous alginate microcapsules (a, b) were compared with highly viscous
alginate microcapsules (c, d). The microcapsules supplemented with PRP (a, c) showed higher viability (green) in both types of alginate
compared to alginate with PRP + PLH groups (b, d). Dead cells were stained by ethidium homodimer (red). Scale bars: 200 µm. The
cell viability was quantified by WST1 assay in medium viscous alginate groups (e) and in highly viscous alginate groups (f). Statistically
significant (P < 0.05) and highly significant (P < 0.01) differences are shown by * and ** on the graph, respectively.
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ranging between 16.37 and 17.35 ng/mg protein, but the
PLH-coated highly viscous alginate preparation secreted
significantly less insulin into the medium (11.88 ± 3.59 ng/
mg protein).
The stimulation index, which was defined as the fold
increase in the secretion level of insulin in response to
the high glucose level, was determined (Figures 6c and
6d). Beta cell functions were found be preserved after the
encapsulation with small variations. The addition of PRP
improved the response to the glucose, but the difference was
not statistically significant compared to the other groups
with medium alginate formulations. The PLH coating in
these microbeads slightly decreased the response to the
stimulus, but opposite results were obtained in the PLHcoated group with the highly viscous alginate formulation
(Figure 6d). The coating improved the response to the
stimulus in these microbeads, but the stimulation was

insignificant in the PLH-coated microbeads with PRP
supplementation.
To analyze the effect of pH on the polypeptide-coated
microspheres and their secretion capacity, all PLH-coated
groups were incubated in phosphate buffer with different
pH levels (Figure 7). At high pH levels, the secretion
capacity of the High Alg formulation increased, and it was
significantly higher than that of the Med Alg formulation.
The results showed that pH is effective on protein
diffusion: the mass transfer declines at lower (acidic) pH
and increase at higher (basic) pH (Figure 7).
4. Discussion
For a long-term treatment of insulin-dependent diabetes
mellitus, it is important to develop a functional system that
supports insulin secretion in response to varying glucose
levels while protecting against cell-mediated immune

Figure 6. Insulin secretion levels and glucose stimulation index. The secreted insulin levels in the low-glucose (5.5 mM; red bar) and in
the high-glucose (25 mM; blue bar) media were determined by ELISA (a, b). The fold increase in secreted insulin levels in response to
the increased concentrations of glucose in media was determined for medium viscous (c) and highly viscous (d) alginate microcapsules.
Statistically significant differences were indicated by * (P < 0.05) and highly significant differences by ** (P < 0.01).
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Figure 7. BSA release from PLH-coated microcapsules was
evaluated for Med Alg and High Alg formulations at 37 °C.
After 24 h, the protein level secreted to the media was measured.
Asterisk indicates significance difference (P < 0.05) from the
measurement at pH 7.0 in the same alginate formulation.

attacks. The transplantation of encapsulated islets for
the treatment of patients diagnosed with type 1 diabetes
has been successfully practiced for a long time, but the
shortage in islet donor numbers limits its widespread
application (Calafiore et al., 2006; Desai and Shea, 2017).
The improvement in cell viability is not sufficient, and tissue
function should be preserved during the manipulations to
maintain the glucose homeostasis capacity of the islets.
Alginate hydrogels are widely used in microencapsulation
of pancreatic islets with different protocols (Robles et al.,
2014).
During the generation of alginate beads, the viscous
solution of alginate was mixed with cells and then
hydrogels were stabilized by treatment with polycationic
polymers. In the polymerization of the outer layer of
alginate microcapsules, the cationic polymers poly-Llysine and poly-L-ornithine have been frequently used.
However, the study by Strand et al. (2001) demonstrated
that TNF secretion and necrosis were induced by poly-Llysine in alginate capsules. Although the results proposed
that the necrosis- or fibrosis-inducing effect was reduced
by mixing the cationic polymer with the alginate and
also reducing its concentration, the toxic effects were
not completely eliminated. It was shown that toxicity of
cationic polymers depends on the polymer composition
and the cell lines (Prokop et al., 1998). In our study, PLH
was used instead. According to our results, the coating
of the microbeads with PLH did not adversely affect
the cell viability. The viability was even increased in the
coated microbeads with PLH compared to the noncoated
alginate microbeads. The cell viability was decreased only
in the microbeads processed with both PLH and PRP.
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The decrease in the viability might be explained by the
stiffness of the microcapsules that originated due to the
PRP. This characteristic of PRP was reported previously
(Horimizu et al., 2013): the thickening of the outer layer
by polycationic polymer might also cause insufficient
nutrient and oxygen intake and lead to decrease in
viability at small scale. However, despite decreased cell
viability, the insulin secretion level from microbeads was
not reduced. This might indicate the effect of the PLH
on the controlled drug release. The swelling of Med Alg
was greater than that of High Alg, which means greater
fluid flow in and out of the microbeads. However, other
structural components, like PRP and PLH, also influenced
the diffusion rate of metabolites. PLH had a very limited
effect on the swelling character, but the change of pH
was one of the critical factors. In the regulation of insulin
secretion, PLH will limit the produced insulin secretion
out of the microcapsules at pH 7.0 and will release at
physiological normal blood pH (about pH 7.4). PLH in the
structure made the microbeads pH-sensitive polymeric
carriers. Gao et al. (2005) and Lee et al. (2007) showed in
their studies that pH-sensitive micelle formulation caused
the release of the drug by reduced pH in the tumor niche,
even with a small change in pH (pH 7.2 to 6.5). This effect
might be very useful because ketoacidosis is frequently
observed in type I diabetes and causes decreases in blood
pH levels below 7.3. Furthermore, the pH of tissues
does not fall below 7.35 in cases of alcohol abuse or
heavy exercise (Ausländer et al., 2014). For that reason,
this behavior of the PLH makes it ideal for any diabetes
treatment. However, there is no significant alteration in
the insulin release between the groups in medium buffered
at pH 6.5 and at pH 7.4 (unpublished result). Different
from in vivo settings, the in vitro culture conditions allow
to accumulate the metabolites, which cause uncontrolled
acidification. The culture model should be modified and
the controlled release effect by PLH should be validated.
The high number of viable cells in the medium viscous
alginate microbeads could also lead to high insulin
secretion. The cell viability and insulin level demonstrated
almost the same pattern in these microbeads. A major
increase in insulin secretion was observed in the PRPsupplemented groups. The addition of PRP to the alginate
composition supported both cell viability and beta cell
function at the same time due to the rich content of
PRP. Insulin secretion was increased in the alginate with
medium viscosity. Similar results have also been obtained
in other studies with PRP-added alginates. In a study on
chronic periodontitis, PRP was mixed with alginate to
form gels instead of mixing with fibrin, and a clinically
significant improvement was achieved in the PRP-alginate
group (Okuda et al., 2005). Combining different types of
bioactive molecules from the PRP with the biomaterial
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scaffold improves their regenerative capacity (Orive et
al., 2014). Addition of PRP into the alginate microbead
composition was reported to promote both angiogenesis
and regeneration characteristics of the scaffold (Man et al.,
2012). Although PRP improved secretion levels, the main
factor affecting insulin secretion was the viscosity of the
alginate used in the production. The alginate with medium
viscosity supported a higher level of insulin secretion
compared to the highly viscous alginate. The glucuronic
acid/mannuronic acid ratio in the alginate composition
mainly determines its physicochemical characteristics. By
using highly viscous alginate, structural impairments can
be reduced and microcapsules with better morphological
characteristics can be generated (van Schilfgaarde and de
Vos, 1999). The highly viscous alginate solutions could
also produce dense microbeads, which block diffusion
of molecules, like insulin. The results demonstrated
that microbeads generated from highly viscous alginate
solution had less capacity to secrete insulin and weakened
glucose stimulation-response coupling.
Beta cell function was evaluated with the stimulussecretion coupling assay. The response of beta cells to
high glucose level was decreased in the highly viscous
alginate microbeads compared to medium viscous alginate
microbeads. The PLH-coated highly viscous alginate
microcapsules without PRP showed the highest response
compared to other highly viscous alginate groups, but this
response was not distinct when comparing medium viscous
alginate microbeads with or without PRP. The stimulation
index directly indicates the beta cell functionality. Any

disruption in cell functionality will affect the insulin
sensing and the secretion. Therefore, the cells can
continue to secrete insulin, but they can degenerate due to
environmental factors, like PRP or poly-L-histidine. PRP
addition did not improve the beta cell function in medium
viscous alginate groups, but stimulation-response coupling
was preserved. Notably, the PLH-coated microbeads
showed decreased beta cell stimulation-response coupling
due to the diffusion blockage.
In conclusion, the most promising results were
obtained from medium viscous alginate microbeads.
The PLH coating, however, did not improve cell viability
and secretion level in the medium. Quite the reverse, the
blocking of diffusion by the copolymer caused decreased
insulin levels in the medium. On the other hand, the
PRP addition within the matrix structure substantially
improved cell viability and consequently the insulin level
in media, but the glucose stimulation-response coupling
of beta cells was not affected. PRP applications have been
shown to support regeneration processes in many cases.
We also demonstrated that PRP supplementation into
microbeads improved cell viability and preserved the cell
function. These results might facilitate generation of more
functional implants with primary beta cells or pancreatic
islets for the treatment of diabetes.
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